Roylea cinerea
Roylea cinerea · Accepted scientific name
Scientific literature: Very Sparse (3 studies) · ★☆☆☆☆
Roylea cinerea is a versatile plant species that has gained significant attention for its diverse pharmacological potential. Scientific investigations have highlighted its promising anti-HIV and anticarcinomic properties, offering hope for complex disease management. Additionally, the plant exhibits notable antidiabetic activities and serves as an effective antifeedant in various biological contexts. Research also points to its efficacy in addressing conditions related to Plasmodium falciparum, marking it as a subject of interest for antimalarial studies. These multifaceted therapeutic characteristics position the species as a valuable resource in the search for new medicinal compounds.
- Synonyms
- Ballota Cinerea · Phlomis Calycina · 2 more
- Common names
- Not available
- Family
- Lamiaceae
- Distribution
- Asia-Temperate
- Plant Parts
- Not available
Classification
Synonyms
Roylea cinerea is a botanical subject frequently associated with several different scientific names due to historical taxonomic shifts. It is widely recognized as being synonymous with Ballota cinerea in various botanical records. Furthermore, this plant has been identified under the name Phlomis calycina in certain contexts. Other taxonomic classifications have also linked it to the synonyms Roylea calycina and Roylea elegans. Understanding these overlapping names is essential for accurate identification and study within the plant kingdom.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Roylea cinerea is a specialized member of the kingdom Plantae. This plant is classified under the class Equisetopsida and belongs to the order Lamiales. Within this botanical hierarchy, it is further categorized into the family Lamiaceae. It is specifically identified by its unique genus, Roylea. Through these relationships, we gain a deeper understanding of its place in the natural world.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Lamiales |
| Family | Lamiaceae |
| Genus | Roylea |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Roylea cinerea is a distinctive plant species primarily found within the tropical regions of Asia. Its natural distribution spans across the vast landscape of the Indian Subcontinent, making it a notable part of the local flora. Within this region, the plant is commonly documented throughout the diverse terrains of India. It also maintains a significant presence in the mountainous landscapes of Nepal. Furthermore, its range extends into the specific environmental niches of the West Himalaya, showcasing its adaptability to these unique habitats.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Roylea cinerea is a self-supporting plant that typically develops a shrub-like growth form. This sturdy structure allows it to maintain its position within its natural habitat without the need for external support.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Roylea cinerea is a medicinal shrub from the Western Himalayas that holds significant importance in traditional ethnomedicine. Scientific evaluations of the plant have corroborated its long-standing use for treating various ailments, most notably its antidiabetic activity. Research identifies specific compounds within its aerial parts that contribute to managing diabetes effectively. Additionally, the plant extracts demonstrate promising antimalarial properties, supporting its historical role in combating malaria. Beyond these uses, Roylea cinerea also exhibits hepatoprotective activities, offering potential benefits for liver health and disease prevention.
Compounds
Conditions
Roylea cinerea demonstrates significant antiprotozoal potential through its ability to treat the malaria parasite Plasmodium falciparum. In an ethnopharmacological study of medicinal plants from the Garhwal region, this specific plant was identified as having good antiplasmodial activity. Research utilizing a modified [3H]-hypoxanthine incorporation assay confirmed that its extracts can target the erythrocytic stages of the parasite. Specifically, the plant showed an IC50 value of less than 5 μg/ml against the chloroquine- and pyrimethamine-resistant K1 strain. These findings highlight the role of Roylea cinerea as a promising candidate for developing new treatments for vector-borne protozoal diseases.